Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Nucleotides × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 1 Gastrointestinal Neoplasms 1

Interventions

Cisplatin 617 Carboplatin 512 Paclitaxel 495 Cyclophosphamide 456 Radiotherapy 455 Docetaxel 414 Fluorouracil 386 Gemcitabine 368 Doxorubicin 345 Capecitabine 321 Dexamethasone 285 Oxaliplatin 251 Vincristine 238 Leucovorin 238 pembrolizumab 236 Etoposide 233 Bevacizumab 229 Rituximab 210 Prednisone 202 Pemetrexed 182 Cytarabine 181 Drug Therapy 173 Methotrexate 153 Trastuzumab 149 Irinotecan 141 Lenalidomide 123 Filgrastim 120 Nivolumab 113 Chemotherapy, Adjuvant 111 Tamoxifen 108

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01423799 2015-11-13

Neoimmune

Société des Produits Nestlé (SPN)

Phase 3 Completed

Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡